Search

everythinglearnresearchcommunity

for

Search:↓

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

PCOS increases sexual pain and distress in infertile Iranian women.

Addressing body image and weight can help improve female sexual dysfunction.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Finasteride use in young men with hair loss is linked to sexual dysfunction.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Female pattern hair loss does not significantly affect sexual dysfunction.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

A 17-year-old girl was diagnosed with a rare ovarian tumor, emphasizing the need for fertility preservation and psychosocial care.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

PCOS causes sexual dysfunction, needing comprehensive treatment.